Siemens Healthineers (OTCMKTS:SMMNY – Get Rating) was downgraded by stock analysts at Jefferies Financial Group from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday, The Fly reports.
A number of other analysts have also recently weighed in on SMMNY. Morgan Stanley assumed coverage on Siemens Healthineers in a research report on Tuesday, October 18th. They issued an “overweight” rating on the stock. Berenberg Bank lowered their price target on Siemens Healthineers from €75.00 ($76.53) to €54.00 ($55.10) and set a “buy” rating on the stock in a research report on Tuesday, November 8th. JPMorgan Chase & Co. lowered their price target on Siemens Healthineers from €63.10 ($64.39) to €62.10 ($63.37) and set an “overweight” rating on the stock in a research report on Thursday, November 10th. Barclays lowered their price target on Siemens Healthineers from €64.00 ($65.31) to €62.00 ($63.27) and set an “overweight” rating on the stock in a research report on Tuesday, October 4th. Finally, UBS Group upgraded Siemens Healthineers from a “neutral” rating to a “buy” rating in a research report on Thursday, August 25th. One research analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $60.53.
Siemens Healthineers Stock Performance
SMMNY opened at $26.40 on Wednesday. Siemens Healthineers has a 1 year low of $19.44 and a 1 year high of $38.23. The stock’s 50 day simple moving average is $22.99 and its 200-day simple moving average is $24.88.
About Siemens Healthineers
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.
- Get a free copy of the StockNews.com research report on Siemens Healthineers (SMMNY)
- Three CBD Stocks to Dominate a Budding Industry
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Is the 60/40 Portfolio Mix Still in Vogue?
- Institutional Support for Analog Devices Remains High
- Microsoft Shares: Is it Time to Back Up the Truck?
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.